Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Combined stem cell-gene therapy approach seen as potential treatment for cystic fibrosis

21.12.2004


Patients with cystic fibrosis (CF) could potentially be treated using their own stem cells that have been manipulated by gene therapy, suggests a study reported in this week’s Proceedings of the National Academy of Sciences (PNAS). The authors, who represent five institutions, including the University of Pittsburgh School of Medicine and Children’s Hospital of Pittsburgh, demonstrate for the first time that human bone marrow-derived adult stem cells can be coaxed to differentiate into airway epithelial cells and that encoding these cells with the gene that is defective in CF restores an important cellular function essential for keeping the airways clear of mucus and air-borne irritants.



"Our results provide proof of principle that a cell-based therapy using marrow stromal stem cells is both a feasible and promising clinical approach. We plan to further investigate its potential and are hopeful that we can perform a small clinical trial within the next two to three years," noted senior author Jay K. Kolls, M.D., professor of pediatrics, immunology and molecular genetics and biochemistry at the University of Pittsburgh School of Medicine and chief, Division of Pediatric Pulmonology and Laboratory of Lung Immunolgy and Host Defense at Children’s Hospital of Pittsburgh.

CF is the most common, fatal genetic disorder affecting Caucasians and is characterized by a mutation of a gene that sits on the surface of epithelial cells, including those that line the airways in the lungs. The gene, transmembrane conductance regulator (CFTR), is responsible for channeling chloride out of cells, an essential function that influences the level of airway surface liquid. This fluid sits atop the airway cells and provides support for the hair-like projections called cilia that sweep mucus and dirt away from the cell. When the level of liquid is too low, as is the case in CF, mucus builds up and the area becomes an attractive environment for bacteria to colonize and cause infection.


Finding ways to correct the gene defect responsible for CF has been the focus of much research and some clinical studies are even looking at gene therapy approaches. To date, no studies have evaluated the potential of adult stem cells or the use of stem cells in combination with ex vivo gene therapy, whereby the CFTR gene is delivered to the cells in a laboratory setting before their introduction into the patient.

While some studies have suggested the potential for bone marrow derived stem cells to differentiate into airway epithelial cells, Dr. Kolls and his co-authors have provided significant proof. Using a method they developed and report in PNAS, stem cells taken from normal subjects and placed in a culture with mature epithelial cells for 14 days differentiated into the specialized cells, taking on their shape and displaying their characteristic protein markers. Importantly, stem cells aspirated from the bone marrow of three CF patients and co-cultured in the same manner also produced airway epithelial cells, but, as expected, were deficient for the CFTR gene. To correct the genetic flaw, the researchers used the Maloney murine leukemia virus as a vector to shuttle the CFTR gene into the stem cells.

A technique called polymerase chain reaction, or PCR, confirmed the gene was expressed in the newly differentiated airway epithelial cells, reported Guoshun Wang, M.D., D.D.M, of Louisiana State University (LSU), where Dr. Kolls previously had worked, and Bruce A. Bunnell, Ph.D, of Tulane University, the study’s first authors. Moreover, the gene therapy-treated cells from CF patients had the same developmental potential as bone marrow-derived stem cells from healthy people.

To determine whether the gene therapy actually corrected the CFTR defect, the researchers exposed the cells to a medium containing labeled chloride and a molecule that regulates the intake and secretion of salts and water necessary for cellular function. If the CFTR gene were not functioning properly, the chloride taken in by the cell would not be able to be secreted. Yet, as the authors reported, the CFTR-corrected stem cells secreted significantly more chloride than stem cells from CF patients without the inserted gene.

"Being able to demonstrate that the gene permitted enhanced chloride channeling was critical to determining the potential of the stem cell-based therapy in the clinical setting," said Dr. Kolls.

Although he acknowledges that more work needs to be conducted, including developing a way to identify the specific subpopulation of bone marrow stem cells that are key to successful engraftment, Dr. Kolls is optimistic about the possibility that a patient’s own stem cells – which would not be subject to immune system attack – could be manipulated by gene therapy and used successfully as a treatment for CF. The ex vivo approach to gene therapy may offer several advantages, including the ability to screen the cells before actually delivering them to patients. In addition, the virus vector being studied by Dr. Kolls is bigger than others being used in trials and has the capacity for both the gene and its accessory apparatus, which may help ensure long-term function.

To further study the potential of the stem cell approach, including in CF patients, Dr. Kolls and colleagues from Children’s Hospital, in collaboration with the University of Pittsburgh, are seeking funding from the National Institutes of Health (NIH) to establish a center focusing on the development of adult stem cell-based therapies for diseases affecting the lung, heart and blood vessels.

In addition to Drs. Kolls, Wang and Bunnell, other authors of the PNAS study include Richard G. Painter, Ph.D., Nicholas A. Lanson, Jr., Ph.D., and Donna Bertucci, from LSU; Blesilda C. Quiniones, M.D., Susan Tom, Jeffrey L. Spees, Ph.D., Alexandra Peister, Ph.D., and Darwin J. Prockop, M.D., Ph.D., from Tulane; Daniel J. Weiss, M.D., Ph.D., of the University of Vermont College of Medicine; and Vincent G. Valentine, M.D., of the Ochsner Clinic Foundation in New Orleans.

Lisa Rossi | EurekAlert!
Further information:
http://www.upmc.edu
http://www.chp.edu

More articles from Life Sciences:

nachricht Transport of molecular motors into cilia
28.03.2017 | Aarhus University

nachricht Asian dust providing key nutrients for California's giant sequoias
28.03.2017 | University of California - Riverside

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Transport of molecular motors into cilia

28.03.2017 | Life Sciences

A novel hybrid UAV that may change the way people operate drones

28.03.2017 | Information Technology

NASA spacecraft investigate clues in radiation belts

28.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>